This amplification of MDM2, combined with the other histological and immunohistochemical findings, conclusively established the diagnosis of DDLPS with IMT-like features, underscoring the tumor’s aggressive biological behavior and diagnostic complexity. The gene discussed is MDM2; the disease is inflammatory myofibroblastic tumor.